3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
2727
Lung Neoplasms
944
Small Cell Lung Carcinoma
447
Neoplasms
419
Colorectal Neoplasms
407
Breast Neoplasms
355
Melanoma
332
Ovarian Neoplasms
316
Neoplasm Metastasis
280
Pancreatic Neoplasms
251
Squamous Cell Carcinoma of Head and Neck
232
Stomach Neoplasms
227
Carcinoma, Renal Cell
214
Triple Negative Breast Neoplasms
189
Head and Neck Neoplasms
178
Prostatic Neoplasms
152
Esophageal Neoplasms
149
Endometrial Neoplasms
145
Uterine Cervical Neoplasms
139
Urinary Bladder Neoplasms
132
Mesothelioma
115
Carcinoma
106
Carcinoma, Hepatocellular
104
Colonic Neoplasms
103
Carcinoma, Transitional Cell
99
Sarcoma
98
Kidney Neoplasms
74
Mesothelioma, Malignant
72
Cholangiocarcinoma
67
Liver Neoplasms
66
Interventions
amatuximab
1
Pemetrexed
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Severe combined immunodeficiency with sensitivity to ionizing radiation
×
Thoracic
×
Clear all
NCT02357147
2020-03-17
ARTEMIS
Morphotek
Phase 2
Terminated
124 enrolled
10 charts